Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study
No abstract is available for this record.
Bibliographic context
Authors
Sara EllisCatherine BostianAnna J. DonnellyWendy FengKatherine EisenMelanie LeanElizabeth ConlanMichael J. OstacherScott T. AaronsonTrisha Suppes
Watch author
Topics and keywords
psilocybin DepressionChronic PainClinical TrialTreatment-Resistant DepressionVeteransToxicity Clinical Trial PsilocybinDepression (economics)Term (time)PsychiatryOpen labelMedicinePsychologyClinical trialInternal medicineHallucinogenEconomicsPhysicsMacroeconomicsQuantum mechanicsPsychedelics and Drug StudiesPain Management and Placebo EffectForensic Toxicology and Drug Analysis
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
No close related records were found yet.